UPC
NASDAQUniverse Pharmaceuticals Inc.
Price$2.81+0.20 (+7.66%)
2026-03-162026-06-17
News · 26 weeks13-100%
2025-12-212026-06-14
Mix390d
- SEC Filings2(67%)
- Insider1(33%)
Latest news
25 items- INSIDERChief Executive Officer Lai Gang was granted 71,890 units of Class A ordinary shares and was granted 12,610 units of Class B ordinary shares (SEC Form 4)4 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- INSIDERSEC Form 3 filed by Universe Pharmaceuticals Inc.3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- INSIDERSEC Form 3 filed by Universe Pharmaceuticals Inc.3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- INSIDERSEC Form 3 filed by Universe Pharmaceuticals Inc.3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- INSIDERSEC Form 3 filed by new insider Yang Lin (Lydia)3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lai Gang3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- INSIDERSEC Form 3 filed by Universe Pharmaceuticals Inc.3 - Universe Pharmaceuticals INC (0001809616) (Issuer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- PRUniverse Pharmaceuticals INC Announces Effective Date of Dual-Class Share StructureJi'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that all conditions to the implementation of its dual-class share structure have been satisfied and that its dual-class share structure will become effective on the Nasdaq Capital Market on February 13, 2026. In connection with the implementation of its dual-class share structure, the Company amended and restated its memorandum and articles of association and the Company's authorized share capital was changed to US$20,000 divided into 1,800,000,000 class A ordinary shares of pa
- SECSEC Form 20-F filed by Universe Pharmaceuticals Inc.20-F - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Universe Pharmaceuticals Inc.SCHEDULE 13G/A - Universe Pharmaceuticals INC (0001809616) (Subject)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Universe Pharmaceuticals Inc.SCHEDULE 13G/A - Universe Pharmaceuticals INC (0001809616) (Subject)
- SECSEC Form 20-F filed by Universe Pharmaceuticals Inc.20-F - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- PRUniverse Pharmaceuticals INC Announces Share ConsolidationJiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the "Share Consolidation"). As a result of the Share Consolidation, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders. Th
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- SECSEC Form 6-K filed by Universe Pharmaceuticals Inc.6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
- PRUniverse Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual ReportJi'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (the "Form 20-F") and that this matter serves as an additional basis for delisting the Company's securities from Nasdaq. The failure to timely file the Form 20-F is a violation of Nasdaq Listing Rule 5250(c)(1). The Com
UPC FAQ
6 questionsWhat does Universe Pharmaceuticals Inc. do?
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals...Where does UPC stock trade?
Universe Pharmaceuticals Inc. (UPC) is listed on NASDAQ.What sector and industry is UPC in?
Universe Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Universe Pharmaceuticals Inc. go public?
Universe Pharmaceuticals Inc. (UPC) completed its IPO in 2021.What companies are similar to UPC?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare UPC side-by-side with any of them on Quantisnow.How can I track UPC on Quantisnow?
Quantisnow aggregates Universe Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UPC to receive live email and push alerts on every new disclosure.